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Bacteria isolated from bloodstream 
infections at a tertiary care hospital 
in Dar es Salaam, Tanzania – 
antimicrobial resistance of isolates
To the Editor: Retrospective antimicrobial susceptibility profiles 
from bloodstream infection isolates in Tanzania indicated increasing 
antimicrobial resistance to the first-line and inexpensive antimicrobial 
agents.1 Prospective methicillin-resistant Staphylococcus aureus 
(MRSA) or extended-spectrum beta-lactamase (ESBL) screening 
should be accompanied by watching multidrug-resistant (MDR) 
isolates and their susceptibility to first-line antibiotics. MDR isolates 
in local circulation might still turn out to be susceptible to such 
drugs, as was found at Sant Parmanand Hospital, a 140-bed private, 
tertiary care, multidisciplinary hospital in Delhi. From January to 
November 2010, 5 MDR bacteria were isolated from patients with 
serious infections. 
Isolates were identified by their phenotypic and biochemical 
characterisation. The antibiotic susceptibility was tested by disk 
diffusion methods following the Clinical and Laboratory Standards 
Institute (CLSI) criteria. MDR Gram-negative strains were defined 
to be resistant to meropenem, piperacillin-tazobactam, cefepime, 
amoxicillin-clavulanic acid and amikacin. The 5 MDR Klebsiella 
pneumoniae from 1 133 isolates were isolated from urine in 3 patients 
and from purulent material in 2. Isolates identified included K. 
pneumoniae (468), Escherichia coli (413), Salmonella typhi/paratyphi 
A, B group (32), S. aureus (110), S. citreus (2), Pseudomonas 
aeruginosa (106) and Proteus spp. (2). All 3 MDR isolates from urine 
were susceptible to tigecycline, 2 to ciprofloxacin and 1 each to 
ofloxacin or rifampicin. Both MDR isolates from purulent materials 
were susceptible to tigecycline, ofloxacin and chloramphenicol, while 
1 each was susceptible to aztroenam or rifampicin. 
An annual rather than a 5-year update1 on local antibiotic 
susceptibility profiles would be useful for clinicians, who would be 
able to refer to the previous local antimicrobial susceptibility pattern 
during pilot antibiotic prescription for their patients. This would be 
useful before results of in vitro susceptibility of isolates are available. 
For example, the first-line, inexpensive antimicrobials1 that were 
developed in the 1940s and 1950s would not be the initial choice 
among clinicians managing patients with severe MDR. However, they 
might be the only option available in some cases, even if the in vitro 
susceptibility profiles are dismal.1 
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Dr S Moyo replies: Our 5-year retrospective analysis was aimed at 
establishing the aetiological agents and their antimicrobial resistance 
patterns. We established that MRSA and ESBL were also of public 
health importance in our settings. Since it was a retrospective 
analysis we could not investigate for MDR. We have recently 
shown a high prevalence of ESBL-producing E. coli and Klebsiella 
spp. strains from urine samples, and most of the ESBL-producing 
isolates were MDR, limiting available therapeutic choices.1 We are 
currently conducting another prospective study to monitor the trends 
of MRSA and to determine the presence of MDR. These results, 
together with the previous ones, will guide antimicrobial prescribing 
practice by our clinicians. MDR bacteria may be susceptible to 
the first-line antibiotics, but this was not apparent in our study. In 
vitro susceptibility results may not necessarily reflect what would 
happen in vivo. Our view is that when managing patients with severe 
infections due to MDR organisms, the first-line antibiotics should 
not be used in order to reduce morbidity and mortality that could be 
associated with life-threatening infections. In tertiary hospitals like 
ours or the authors’, first-line antibiotics might not be the only option 
available for management of such cases, as suggested.
Tonsillectomy practice in South Africa
To the Editor: Tonsillectomy is a very common operation done 
by ENT surgeons and general practitioners in South Africa. Our 
impression is that the procedure and its peri-operative care vary 
greatly. We conducted a web-based survey (approved by the UCT 
ethics committee) to evaluate tonsillectomy practice among South 
African ENT surgeons and discuss the findings in relation to 
evidence-based practice from the literature. We report only on the 
controversial and interesting aspects. Ninety-three surgeons (27% of 
the ENT surgeons in active practice in South Africa) completed the 
survey, of whom 65 were in private practice.
Method of tonsillectomy. Sixty per cent of both public and 
state surgeons remove tonsils by conventional cold steel dissection, 
which has a lower bleeding rate than more recent techniques such as 
coblation and bipolar dissection.1
Corticosteroids. Forty-seven per cent of surgeons use peri-
operative steroids. A Cochrane Library report includes Grade A 
supporting evidence that a single intravenous dose of dexamethasone 
is effective, relatively safe and inexpensive in reducing morbidity 
(pain, nausea and vomiting).2
Antibiotics. Sixty per cent of surgeons prescribe antibiotics, of 
whom 42% prescribe amoxicillin/clavulanic acid (Augmentin) and 
38% amoxicillin. Although many surgeons believe these prevent 
postoperative bleeding, this is not supported by the literature.3
Local anaesthesia. Seventeen per cent of surgeons inject the 
tonsil bed with local anaesthetic. Although not believed to benefit 
postoperative pain, the latest systematic review seems to show a 
modest reduction in postoperative pain, and we suggest it as an 
adjunct to the normal analgesia.4
Postoperative pain. Tonsillectomy patients experience a great 
deal of pain. The mean time for cessation of pain is 11 days;5 most 
surgeons (80%) agreed with this. Eighty-nine per cent of respondents 
warned their patients about the 5 - 6-day ‘dip’, when patients typically 
called their surgeon and reported that pain had increased, and 
that they couldn’t eat, had become pyrexial and wished to visit the 
surgeon. There is only one report about this ‘dip’, in the journal Pain, 
which simply stated that pain declines after 3 days, but that 30% of the 
sample population made an unscheduled stop at the doctor between 
days 4 and 7.6
Postoperative chewing gum. Forty-nine per cent of surgeons 
advised patients to chew gum to reduce masseter muscle spasm 
and relieve pain. Only one study could be found that addressed this 
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